Related references
Note: Only part of the references are listed.Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection
Masafumi Fukuda et al.
JOURNAL OF NEUROSURGERY (2011)
The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36
W. J. Neary et al.
CLINICAL OTOLARYNGOLOGY (2010)
Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2
W. J. Neary et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2010)
Spontaneous regression of vestibular schwannomas after resection of contralateral tumor in neurofibromatosis Type 2 Report of 2 cases
Kajetan L. von Eckardstein et al.
JOURNAL OF NEUROSURGERY (2010)
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner et al.
NEURO-ONCOLOGY (2010)
Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas
K. D. Hadfield et al.
ONCOGENE (2010)
Radiosurgical Treatment of Vestibular Schwannomas in Patients with Neurofibromatosis Type 2
Ji Hoon Phi et al.
CANCER (2009)
Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2
D. Gareth Evans et al.
CLINICAL CANCER RESEARCH (2009)
Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2
Eiji Ito et al.
NEUROSURGICAL REVIEW (2009)
Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II
Gordon J. Harris et al.
NEUROSURGERY (2008)
Auditory Brainstem implant in Neurofibromatosis Type 2 and Non-Neurofibromatosis Type 2 Patients
Alexis Bozorg Grayeli et al.
OTOLOGY & NEUROTOLOGY (2008)
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy
Scott R. Plotkin et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications, and hearing preservation rates
David Mathieu et al.
NEUROSURGERY (2007)
Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2
ME Baser et al.
JOURNAL OF MEDICAL GENETICS (2005)
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought
DGR Evans et al.
OTOLOGY & NEUROTOLOGY (2005)
Vestibular schwannoma growth rates in Neurofibromatosis type 2 Natural History consortium subjects
WH Slattery et al.
OTOLOGY & NEUROTOLOGY (2004)
Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis
JG Rowe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma
J Kanzaki et al.
OTOLOGY & NEUROTOLOGY (2003)
Continuous growth of mean tumor diameter in a subset of grade II gliomas
E Mandonnet et al.
ANNALS OF NEUROLOGY (2003)
Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2
ME Baser et al.
JOURNAL OF NEUROSURGERY (2002)
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study
VF Mautner et al.
JOURNAL OF NEUROSURGERY (2002)
Results of acoustic neuroma radiosurgery: an analysis of 5 years' experience using current methods
JC Flickinger et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
